Synonyms: GR-43659X | GR43659X | GX 1048 | GX-1048 | GX1048 | Lacipil® | Molap® | Motens®
lacidipine is an approved drug (UK (2013))
Compound class:
Synthetic organic
Comment: Lacidipine (GR-43659X) is dihydropyridine calcium channel blocker. It has a slow onset of activity and a long duration of action.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (UK (2013)) |
IUPAC Name |
diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate |
International Nonproprietary Names | |
INN number | INN |
6093 | lacidipine |
Synonyms |
GR-43659X | GR43659X | GX 1048 | GX-1048 | GX1048 | Lacipil® | Molap® | Motens® |
Database Links | |
CAS Registry No. | 103890-78-4 (source: WHO INN record) |
DrugBank Ligand | DB09236 |
GtoPdb PubChem SID | 458923775 |
PubChem CID | 5311217 |
Search Google for chemical match using the InChIKey | GKQPCPXONLDCMU-CCEZHUSRSA-N |
Search Google for chemicals with the same backbone | GKQPCPXONLDCMU |
Search PubMed clinical trials | lacidipine |
Search PubMed titles | lacidipine |
Search PubMed titles/abstracts | lacidipine |
UniChem Compound Search for chemical match using the InChIKey | GKQPCPXONLDCMU-CCEZHUSRSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | GKQPCPXONLDCMU-CCEZHUSRSA-N |